|
DYRK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.87641046934095E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.86277684785819E-14 |
| Normal-vs-Stage2 |
4.589600E-04 |
| Normal-vs-Stage3 |
1.23379999994455E-06 |
| Normal-vs-Stage4 |
9.97419999999583E-05 |
| Stage1-vs-Stage2 |
2.517800E-01 |
| Stage1-vs-Stage3 |
6.759700E-02 |
| Stage1-vs-Stage4 |
5.355800E-02 |
| Stage2-vs-Stage3 |
8.575600E-01 |
| Stage2-vs-Stage4 |
6.786200E-01 |
| Stage3-vs-Stage4 |
7.578200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.29558643999917E-13 |
| Normal-vs-AfricanAmerican |
1.820030E-03 |
| Normal-vs-Asian |
8.255200E-03 |
| Caucasian-vs-AfricanAmerican |
1.915840E-01 |
| Caucasian-vs-Asian |
3.781600E-02 |
| AfricanAmerican-vs-Asian |
1.177720E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.46990197791297E-11 |
| Normal-vs-Female |
7.64860397239886E-11 |
| Male-vs-Female |
7.405200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.355400E-03 |
| Normal-vs-Age(41-60Yrs) |
7.61946061800245E-13 |
| Normal-vs-Age(61-80Yrs) |
7.22329973612545E-10 |
| Normal-vs-Age(81-100Yrs) |
1.028370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.639400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.799200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.092160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.415800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.250400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.028830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.416000E-03 |
| Normal-vs-Grade 2 |
1.83886239568665E-12 |
| Normal-vs-Grade 3 |
2.25209995097231E-09 |
| Normal-vs-Grade 4 |
5.152500E-04 |
| Grade 1-vs-Grade 2 |
8.708200E-01 |
| Grade 1-vs-Grade 3 |
3.596400E-01 |
| Grade 1-vs-Grade 4 |
2.498400E-01 |
| Grade 2-vs-Grade 3 |
5.295900E-02 |
| Grade 2-vs-Grade 4 |
4.127600E-02 |
| Grade 3-vs-Grade 4 |
4.238200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.67033054054855E-12 |
| Normal-vs-ccB subtype |
2.89729995550658E-09 |
| ccA subtype-vs-ccB subtype |
3.090000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97489802289397E-11 |
| Normal-vs-N1 |
3.438300E-02 |
| N0-vs-N1 |
7.527600E-01 |
|
|
